KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Revenue: 2009-2024

Historic Revenue for Ionis Pharmaceuticals (IONS) over the last 16 years, with Dec 2024 value amounting to $705.1 million.

  • Ionis Pharmaceuticals' Revenue rose 17.12% to $156.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $792.9 million, marking a year-over-year decrease of 1.26%. This contributed to the annual value of $705.1 million for FY2024, which is 10.48% down from last year.
  • Ionis Pharmaceuticals' Revenue amounted to $705.1 million in FY2024, which was down 10.48% from $787.6 million recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' Revenue ranged from a high of $787.6 million in FY2023 and a low of $60.0 million during FY2021.
  • Moreover, its 3-year median value for Revenue was $705.1 million (2024), whereas its average is $693.4 million.
  • In the last 5 years, Ionis Pharmaceuticals' Revenue spiked by 1,983.61% in 2020 and then crashed by 91.77% in 2021.
  • Ionis Pharmaceuticals' Revenue (Yearly) stood at $729.3 million in 2020, then tumbled by 91.77% to $60.0 million in 2021, then surged by 878.95% to $587.4 million in 2022, then skyrocketed by 34.10% to $787.6 million in 2023, then dropped by 10.48% to $705.1 million in 2024.